Beskrivelse
Krav
Fullmektig i Norge:
Org.nummer: 986406263
- Org.nummer:
- Foretaksnavn:
- Foretaksform:
- Næring:
-
Forretningsadresse:
Fullmektig i EP:
2018.10.16, US 201862746524 P
2018.10.18, US 201862747587 P
2019.04.24, US 201962838049 P
BADE, MA et al.: "Endovascular abdominal aortic aneurysm repair in a patient with Ehlers-Danlos syndrome", Journal of Vascular Surgery, vol. 46, no. 2, 2007, pages 360-362, XP022694574, DOI: 10.1016/j.jvs.2007.03.045 (B1)
BERIDZE NATALIA ET AL: "Vascular Ehlers-Danlos syndrome: pathophysiology, diagnosis, and prevention and treatment of its complications", CARDIOLOGY IN REVIEW, LIPPINCOTT WILLIAMS & WILKINS, US, vol. 20, no. 1, 31 December 2011 (2011-12-31), pages 4-7, XP009508098, ISSN: 1538-4683, DOI: 10.1097/CRD.0B013E3182342316 (B1)
DE-A1-102004 019 413 (B1)
DOYLE JEFFERSON J ET AL: "A deleterious gene-by-environment interaction imposed by calcium channel blockers in Marfan syndrome", ELIFE, vol. 4, 27 October 2015 (2015-10-27), pages 1-18, XP55927548, DOI: 10.7554/eLife.08648 Retrieved from the Internet: URL:https://elifesciences.org/download/aHR 0cHM6Ly9jZG4uZWxpZmVzY2llbmNlcy5vcmcvYXJ0a WNsZXMvMDg2NDgvZWxpZmUtMDg2NDgtdjIucGRmP2N hbm9uaWNhbFVyaT1odHRwczovL2VsaWZlc2NpZW5jZ XMub3JnL2FydGljbGVzLzA4NjQ4/elife-08648-v2 .pdf?_hash=r04QPSlSb9gDPDGbczCnQo3PyIspiq7 Uedu4zQ0JqK0=> (B1)
WO-A1-2018/160987 (B1)
LEPPANEN, T et al.: "Protein Kinase C and its Inhibitors in the Regulation of Inflammation: Inducible Nitric Oxide Synthase as an Example", Basic & Clinical Pharmacology & Toxicology, vol. 114, 2014, pages 37-43, XP055529503, DOI: 10.1111/bcpt.12139 (B1)
LIN, Y et al.: "Genetic variants in PLCB4/PLCB1 as susceptibility loci for coronary artery aneurysm formation in Kawasaki disease in Han Chinese in Taiwan", Scientific Reports, vol. 5, 5 October 2015 (2015-10-05), pages 1-12, XP55710153, (B1)
SHARP, TE et al.: "Protein Kinase C Inhibition With Ruboxistaurin Increases Contractility and Reduces Heart Size in a Swine Model of Heart Failure With Reduced Ejection Fraction", JACC: Basic to Translational Science, vol. 2, no. 6, 2017, pages 669-683, XP55710149, (B1)
WO-A1-2017/079399 (B1)
HE, X et al.: "Targeting PKC in Human T Cells Using Sotrastaurin (AEB071) Preserves Regulatory T Cells and Prevents IL -17 Production", Journal of Investigative Dermatology, vol. 134, no. 4, 2014, pages 975-983, XP055806835, (B1)
Statushistorie
Hovedstatus | Beslutningsdato, detaljstatus |
---|---|
EP patent gjort gjeldende i Norge | EP patent besluttet gjeldende i Norge |
EP under behandling | Forespørsel om å gjøre EP patent gyldig er mottatt |
Korrespondanse
Dato
Type korrespondanse
Journal beskrivelse
|
---|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Utgående
EP Varsel om betaling av første årsavgift (3319) (PTEP3866799)
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Utgående
EP Registreringsbrev (3210) (PTEP3866799)
|
Innkommende, AR602098968
Søknadsskjema Patent
|
Innkommende
EP Publiseringsdokument fra EPO
|
Til betaling:
Betalingshistorikk:
Beskrivelse / Fakturanummer | Betalingsdato | Beløp | Betaler | Status |
---|---|---|---|---|
Årsavgift 6. avg. år (EP) | 2024.10.29 | 2600 | COMPUTER PACKAGES INC. | Betalt og godkjent |
32402937 expand_more expand_less | 2024.02.27 | 5580 | PLOUGMANN VINGTOFT NUF | Betalt |
Gebyr ved bruk av MasterCard-kort
80 = 80 X 1
Valideringsgebyr EP-patent
5500 = 1 X 5500
|